December 30, 2016
Ultragenyx Gives Arcturus Rocket Shot in Potential $1.57B Deal
Read More
November 30, 2016
NYT: Johnson & Johnson Has Its Eye on Actelion
Read More
December 18, 2015
DARZALEX® (daratumumab) Approved by U.S. FDA First Available Treatment for Multiple Myeloma
Read More
December 14, 2013
New Drug Brings Relief for Rare Disease
Read More
September 17, 2013
Johnon & Johnson Files Multicentric Castleman Disease Drug, Siltuximab, in US and EU
Read More
August 19, 2011
EVERYLIFE Foundation Blog – FDA Commissioner Appoints New Leadership
Read More
April 21, 2009
A Mom Brokers Treatment For Her Twins' Rare and Fatal Illness
Read More
X